BioPharm Insight
The Leading Provider of Intelligence to the Biotechnology & Pharmaceutical Industry
- Detailed company profiles for over 4,100 biotech & pharmaceutical companies
- Listings on 36,000+ investigational & 23,000+ approved drugs
- Contact info for 250,000+ industry contacts (includes email & direct phone)
- Product forecasts to 2018
- Pharmawire - Proprietary, Competitive Intelligence.
Our Pharmawire journalists cover the most important situations taking place in the life sciences industry. They tap leading CEOs, scientists, clinicians, lawyers, and other experts to provide forward looking insight into drug pipelines, upcoming litigation (including patent expirations), drug licensing deals, and mergers & acquisitions.
Pharmawire Intelligence
Endocyte narrows CRO search for Phase III ovarian cancer trial; financing still being secured, CFO says
Kissei working with CRO Richmond Pharmacology for Phase I endometriosis trial; recruitment delays occurring
Oculus looks for opportunistic buys but synergistic alliances are current focus - CEO